Identification of CEACAM5 as a stemness-related inhibitory immune checkpoint in pancreatic cancer

被引:0
作者
Haojun Shi
Yiusing Tsang
Yisi Yang
机构
[1] Ruijin Hospital,Department of General Surgery
[2] Shanghai Jiao Tong University School of Medicine,Graduate School of Asia
[3] Shanghai Institute for Endocrine and Metabolic Diseases,Pacific Studies
[4] Ruijin Hospital,undefined
[5] Shanghai Jiao Tong University School of Medicine,undefined
[6] Waseda University,undefined
来源
BMC Cancer | / 22卷
关键词
Pancreatic cancer; Cancer stemness; CEACAM5; Immune checkpoint; Immunotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 421 条
[11]  
Buchler MW(2016)Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy Nat Med 22 851-860
[12]  
Park W(2019)UVB-Induced tumor heterogeneity diminishes immune response in melanoma Cell 179 219-235.e221
[13]  
Chawla A(2016)Cancer stem cells: basic concepts and therapeutic implications Annu Rev Pathol 11 47-76
[14]  
O'Reilly EM(2016)Metastatic colonization by circulating tumour cells Nature 529 298-306
[15]  
Carlino MS(2007)Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell 1 313-323
[16]  
Larkin J(2014)An integrin beta(3)-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition Nat Cell Biol 16 457-468
[17]  
Long GV(2019)CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth Nat Cell Biol 21 1425-1435
[18]  
Wang M(2008)Efficient tumour formation by single human melanoma cells Nature 456 593-598
[19]  
Herbst RS(2019)Adaptive immune resistance emerges from tumor-initiating stem cells Cell 177 1172-1186.e1114
[20]  
Boshoff C(2021)CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance Cell Stem Cell 28 1597-1613.1597